Penicillin Allergy in Shfayim Clinic
NCT03499457 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2018-04-17
Summary
revising penicillin allergy in the medical records, by taking full medical history and giving a challange test, in order to imrove the medical records and treatment possibilities.
Conditions
- Penicillin Allergy
Interventions
- DRUG
-
Amoxicillin
chalange test of 50 mg, and after an hour 500 mg
Sponsors & Collaborators
-
Clalit Health Services
lead OTHER
Principal Investigators
-
lital f goldberg, MD. MPH · Clalit Health Services
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 5 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-30
- Primary Completion
- 2019-01-31
- Completion
- 2019-06-30
More Related Trials
-
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
NCT03463135 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of Perennial Allergic Rhinitis In Pediatrics
NCT00253058 ·Status: COMPLETED ·Phase: PHASE3
-
Perennial Allergic Rhinitis In Pediatric Subjects
NCT00257595 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
NCT00599872 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability of SLIT With LAIS® Mites Allergoid Tablets
NCT02609581 ·Status: COMPLETED
-
A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
NCT03443843 ·Status: COMPLETED ·Phase: PHASE4
-
Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment
NCT03097432 ·Status: COMPLETED
-
A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube
NCT00985075 ·Status: COMPLETED
-
Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber
NCT00836914 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
NCT00813748 ·Status: COMPLETED
-
A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients
NCT07194824 ·Status: TERMINATED ·Phase: NA
-
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
NCT00348361 ·Status: COMPLETED ·Phase: PHASE1
-
ILIT: Follow-up of Rhinitis Quality of Life
NCT05037955 ·Status: COMPLETED
-
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00453583 ·Status: COMPLETED
-
Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets
NCT02553590 ·Status: COMPLETED
-
Penicillin De-labeling in the Pediatric Primary Care Setting
NCT05010304 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 ·Status: COMPLETED
-
A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy
NCT03819881 ·Status: UNKNOWN ·Phase: PHASE1
-
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
NCT03558997 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
NCT03293225 ·Status: COMPLETED
-
Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais
NCT01115595 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Allergen Challenge in Rhinitic Subjects
NCT01286129 ·Status: COMPLETED ·Phase: NA
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)
NCT00794495 ·Status: COMPLETED ·Phase: PHASE4